Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Oxford Science Enterprises Information
Geographic Data
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Financial Info
Stage:
Raised Last:
$299M
Raised Total:$300M
Social
Twitter
Linkedin
Crunchbase
Metrics
4,299,602Website Global Rank
2,884Website Monthly Traffic
Twitter Followers
Description
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2023 | Quantum Motion | Series B | 0 |
| 5/2020 | Quantum Motion Technologies | Series A | 9.8M |
| 4/2022 | OMass Technologies | Series B | 0 |
| 12/2017 | Theolytics | Seed Round | 3.4M |
| 11/2016 | Vaccitech | Seed Round | 12.4M |
| 5/2017 | Ultromics | Seed Round | 2.6M |
| 2/2022 | First Light Fusion | Series C | 45M |
| 8/2017 | OxMet Technologies | Seed Round | 2.6M |
| 6/2020 | Oxford Ionics | Seed Round | 3.4M |
| 5/2016 | Evox Therapeutics | Series A | 14.4M |
| 3/2016 | Diffblue | Seed Round | - |
| 12/2021 | Alethiomics | Seed Round | 8M |
| 12/2016 | EnzBond | Seed Round | 445.3k |
| 6/2022 | ORCA Computing | Series A | 15M |
| 1/2016 | Oxford Flow | Seed Round | - |
| 10/2016 | DJS Antibodies | Seed Round | - |
| 8/2018 | Edplus | Pre Seed Round | 643.5k |
| 5/2019 | Albus Health | Convertible Note | 580.9k |
| 7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
| 3/2017 | Oxford Semantic Technologies | Seed Round | - |
| 9/2018 | Oxford VR | Venture Round | 4.2M |
| 6/2017 | Scenic Biotech | Series A | 7.3M |
| 1/2016 | Mixergy Ltd. | Seed Round | - |
| 5/2021 | Omega Crop | Seed Round | 1.7M |
| 12/2018 | Genomics | Series B | 9.1M |
| 1/2020 | OxMet Technologies | Series B | 14.1M |
| 3/2021 | Genomics | Venture Round | 30M |
| 7/2021 | Orbit Discovery | Venture Round | 0 |
| 11/2017 | Quantum Motion Technologies | Seed Round | - |
| 11/2015 | Bodle Technologies | Seed Round | - |
| 1/2018 | Pepgen | Seed Round | - |
| 10/2016 | Argonaut Therapeutics | Seed Round | - |
| 7/2019 | Zegami | Series B | 1.6M |
| 4/2020 | BibliU | Series A | 10M |
| 12/2021 | ONI | Series B | 75M |
| 6/2015 | OxStem | Seed Round | - |
| 12/2022 | BehaVR | Series B | 0 |
| 12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
| 6/2018 | BibliU | Seed Round | 3.8M |
| 3/2018 | Xerion Healthcare | Venture Round | 2.8M |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 1/2017 | Covatic | Seed Round | 896.6k |
| 3/2021 | Caristo Diagnostics | Venture Round | - |
| 2/2017 | BibliU | Seed Round | 1.4M |
| 7/2018 | ONI | Series A | 24M |
| 2/2020 | Oxford VR | Series A | 0 |
| 10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
| 8/2019 | MoA Technology | Series A | 7.6M |
| 11/2022 | Util | Seed Round | 0 |
| 6/2018 | Metaboards | Series A | 0 |
| 7/2020 | PQShield | Seed Round | 6.9M |
| 4/2018 | Oxford Flow | Venture Round | 8.5M |
| 7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
| 1/2021 | Living Optics | Seed Round | 0 |
| 5/2018 | Orbit Discovery | Series A | 0 |
| 11/2017 | First Light Fusion | Venture Round | - |
| 1/2017 | Oxford VR | Seed Round | - |
| 10/2018 | Animal Dynamics | Series A | 0 |
| 5/2018 | Ultromics | Series A | 0 |
| 6/2022 | BibliU | Series B | 0 |
| 9/2018 | Evox Therapeutics | Series B | 0 |
| 12/2021 | Navenio | Venture Round | 0 |
| 7/2019 | Zegami | Series B | 1.6M |
| 7/2021 | Rey | Series A | 10M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 12/2019 | Mixergy Ltd. | Series A | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 6/2020 | Base Genomics | Seed Round | 11.3M |
| 5/2018 | Opsydia | Seed Round | 2.5M |
| 6/2023 | Beacon Therapeutics | Series A | 0 |
| 2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
| 9/2022 | Opsydia | Venture Round | 0 |
| 4/2020 | Perspectum | Series B | 35.9M |
| 5/2016 | ONI | Seed Round | 1.7M |
| 10/2019 | MiroBio | Series A | 33.2M |
| 8/2017 | Inkpath | Series A | - |
| 2/2018 | Latent Logic | Seed Round | 2M |
| 7/2020 | ORCA Computing | Pre Seed Round | - |
| 6/2020 | Oxford Flow | Venture Round | 0 |
| 6/2022 | MiroBio | Series B | 0 |
| 5/2018 | PQShield | Seed Round | - |
| 3/2021 | Vaccitech | Series B | 168M |
| 5/2018 | Util | Seed Round | 1.1M |
| 10/2018 | Covatic | Seed Round | 1.1M |
| 6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
| 2/2021 | Evox Therapeutics | Series C | 96.7M |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 9/2016 | Iota Sciences | Seed Round | - |
| 12/2020 | DJS Antibodies | Venture Round | 0 |
| 3/2017 | Bodle Technologies | Seed Round | - |
| 6/2015 | Proxisense | Seed Round | - |
| 11/2017 | Albus Health | Convertible Note | 66.6k |
| 6/2017 | Diffblue | Series A | 21.8M |
| 1/2022 | PQShield | Series A | 0 |
| 12/2020 | Pepgen | Series A | 45M |
| 8/2021 | Pepgen | Venture Round | 0 |
| 12/2015 | Navenio | Seed Round | 2.6M |
| 3/2017 | SpyBiotech | Seed Round | 5M |
| 7/2022 | Brill Power | Series A | 0 |
| 5/2022 | Salience Labs | Seed Round | 11.5M |
| 1/2018 | Bodle Technologies | Series A | 8.5M |
| 11/2018 | OMass Technologies | Series A | 17.9M |
| 6/2016 | OMass Technologies | Seed Round | 1.4M |
| 2/2020 | OMass Technologies | Series A | 35.8M |
| 12/2020 | T-Cypher Bio | Seed Round | - |
| 2/2016 | Mind Foundry | Seed Round | 1.7M |
| 9/2011 | Oxtex | Seed Round | 800k |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 6/2017 | Zegami | Series A | 3M |
| 1/2018 | Vaccitech | Series A | 0 |
| 1/2021 | Theolytics | Series A | 6.8M |
| 11/2022 | Osler Diagnostics | Series C | 0 |
| 9/2017 | Oxford Quantum Circuits | Series A | - |
| 4/2017 | ONI | Seed Round | 3.7M |
| 8/2018 | Genomics | Series B | 32.5M |
| 11/2018 | OxMet Technologies | Series A | 7.8M |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 9/2018 | Oxford VR | Seed Round | 4.2M |
| 4/2020 | Living Optics | Seed Round | 4.1M |
| 3/2017 | Pro-Mapp | Seed Round | - |
| 5/2022 | MoA Technology | Series B | 0 |
| 3/2018 | 6D.ai | Seed Round | - |
| 9/2017 | Mind Foundry | Seed Round | 3.4M |
| 4/2021 | Oxford Endovascular | Series A | 0 |
| 8/2021 | Ultromics | Series B | 0 |
| 2/2021 | SpyBiotech | Series A | 32.5M |
| 9/2019 | YASA | Series C | 22.2M |
| 11/2020 | Refeyn | Series A | 30M |
| 8/2018 | BioBeats | Seed Round | 3M |
| 12/2017 | Navenio | Funding Round | 7.7M |
| 5/2020 | Navenio | Series A | 0 |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Quantum Motion | Series B | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 11/2022 | Osler Diagnostics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
